Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease

Naoko Harada, Koichi Sayama, Kyuto Tanaka, Naoki Hasegawa, Shinichiro Okamoto, Yuichiro Hayashi, Akitoshi Ishizaka

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint Dive into the research topics of 'Long-term treatment with a humanized anti-interleukin-6 receptor antibody (tocilizumab), improving interstitial pneumonia in a patient with multicentric Castleman disease'. Together they form a unique fingerprint.

Medicine & Life Sciences